9 Meters Biopharma, Inc.

Another company joined the burgeoning obesity therapy space on 28 January, as Versant Ventures-backed Helicore Biopharma unveiled a $65m series A financing and initial plans to take a first-in-class

Since it has become difficult for many biopharmaceutical companies to raise money during the past year and a half, several firms have been forced to cut costs to make remaining cash balances last long

With investors closely watching how biopharmaceutical companies are spending the cash they have on hand so that they do not run out of money in a tough fundraising environment, even firms with revenue

Things are looking up for Zealand Pharma A/S as it enters the final quarter of a difficult year with the Danish biotech securing a significant cash injection after presenting promising late-stage da